Revisiting the anticardiolipin test and its standardization

Lupus

Volumn 11, Issue 5, 2002, Pages 269-275

  Harris, EN ^a   Pierangeli, S S ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

Anticardiolipin antibodies; Anticardiolipin calibrators; Antiphospholipid syndrome; Standardization

Indexed keywords

CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN A; MONOCLONAL ANTIBODY; IMMUNOGLOBULIN M;

ANTIPHOSPHOLIPID SYNDROME; CALIBRATION; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MEASUREMENT; PRIORITY JOURNAL; REPRODUCIBILITY; REVIEW; STANDARDIZATION; VALIDATION PROCESS; ANALYTICAL EQUIPMENT; ARTICLE; BLOOD; IMMUNOLOGY; STANDARD;

ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, MONOCLONAL; ANTIPHOSPHOLIPID SYNDROME; CALIBRATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; HUMANS;

EID: 0035985646     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203302lu202cr     Document Type: Review

References (36)

1. Anticardiolipin antibodies: Detection by radioimmunoassay and association with thrombosis
2. Antiphospholipid syndrome
3. Syndrome of the black swan
4. Measurement of anticardiolipin antibodies and biological false positive serological tests for syphilis in patients with systemic lupus erythematosus
5. Anticardiolipin antibody isotype distribution and phospholipid specificity
6. Anticardiolipin (ACA) antibodies directed not to cardiolipin but to a plasma protein cofactor
7. Anticardiolipin antibodies directed not to cardiolipin but to a plasma protein cofactor
8. 2glycoprotein I (apolipoprotein H)
9. 2glycoprotein I structure altered by interacting with an oxygen modified solid phase surface
10. 2glycoprotein I in the absence of phospholipid: Importance of antigen density and bivalent binding
11. Cross-reactivity of antiphospholipid antibodies
12. Antiphospholipid antibodies and recurrent pregnancy loss: Correlation between the activated partial thromboplastin time and antibodies against phosphatidylserine and cardiolipin
13. 2glycoprotein I
14. Lupus anticoagulant IgG's (LA) are not directed against to phospholipids only, but to a complex of lipid-bound prothrombin
15. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C or protein S: An explanation for their pathogenic mechanism?
16. Thrombosis, recurrent fetal loss and thrombocytopenia: Predictive value of the anti-cardiolipin test
17. Accuracy of anticardiolipin antibodies in identifying a history of thrombosis among patients with systemic lupus erythematosus
18. IgG anticardiolipin antibody titer > 40 GPL and the risk of subsequent thrombo-occlusive events and death
19. Evaluation of the anticardiolipin antibody test: Report of an international workshop held April 4 1986
20. The second international anticardiolipin standardization workshop: The Kingston Antiphospholipid Antibody Study (KAPS) group
21. Anticardiolipin wet workshop report: Vth International Symposium on Antiphospholipid Antibodies
22. Report of an anticardiolipin workshop during the VIIth International Symposium on antiphospholipid antibodies
23. Multicenter evaluation of nine commercial kits for the quantitation of anticardiolipin antibodies
24. Interlaboratory variation in antiphospholipid antibody testing
25. Anticardiolipin antibody assay: A methodolgical analysis for a better consensus in routine determinations-a cooperative project of the European Antiphospholiid Forum
26. Annotation: Antiphospholipid antibodies
27. 2glycoprotein I antibodies
28. Anticardiolipin antibodies: Clinical consequences of 'low titers'
29. IgA anticardiolipin antibodies-relation with other antiphospholipid antibodies and clinical significance
30. 2glycoprotein I antibodies in Jamaican and African-American SLE patients
31. Clinical significance of immunoglobulin A versus immunoglobulins G and M anticardiolipin antibodies in patients with systemic lupus erythematosus: Correlation with thrombosis, thrombocytopenia and recurrent abortion
32. 2glycoprotein I are the most prevalent isotypes in African American patients with systemic lupus erythematosus
33. Testing for antiphospholipid antibodies: Problems and solutions
34. Advances in antiphospholipid antibody testing
35. 'Equivocal' antiphospholipid syndrome
36. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome